As reported previously, LINC01929 functioned as a tumor-promoting molecule in oral squamous cell carcinoma by accelerating cell proliferation, migration, and invasion, and suppressing apoptosis, suggesting that it may be a novel target for cancer therapy [26]. This evidence concerns the gene LINC01929 and neoplasm.